Taiko Pharmaceutical Co.,Ltd. (TAIKO PHARMACEUTICAL CO LTD) Aktie
4574.T
GeschlossenTAIKO PHARMACEUTICAL CO LTD
Market Cap
$13,065,309,184
Über Taiko Pharmaceutical Co.,Ltd. (TAIKO PHARMACEUTICAL CO LTD) Aktie
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
Unternehmensinformationen
550-0005 Osaka, Japan
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.